From: miR-155 in the progression of lung fibrosis in systemic sclerosis
KEGG pathway | p value | #genes | miRNA | |||||
---|---|---|---|---|---|---|---|---|
ECM-receptor interaction (hsa04512) | <1e-16 | 16 | 3 | let-7e, | miR-4459, | let-7f | ||
Ubiquitin mediated proteolysis (hsa04120) | <1e-16 | 76 | 9 | miR-182, | miR-141, | miR-125a, | miR-379, | miR-4484, |
miR-574, | miR-3613, | miR-4739, | miR-20a | |||||
Wnt signaling pathway (hsa04310) | <1e-16 | 79 | 10 | miR-155, | miR-205, | miR-1224, | let-7e, | miR-4459, |
miR-762, | miR-4668, | let-7f, | miR-3613, | miR-20a | ||||
MAPK signaling pathway (hsa04010) | <1e-16 | 132 | 13 | miR-21, | miR-155, | miR-125a, | let-73, | miR-4530, |
miR-1207, | miR-149, | miR-762, | let-7f, | miR-199a, | ||||
miR-199b, | miR-3613, | miR-20a | ||||||
Pathways in cancer (hsa05200) | <1e-16 | 166 | 15 | miR-21, | miR-155, | miR-182, | miR-205, | miR-1224, |
let-7e, | miR-4459, | miR-4484, | let-7f, | miR-199a, | ||||
miR-574, | miR-199b, | miR-3613, | miR-4739, | miR-20a | ||||
Axon guidance (hsa04360) | 7.77E-16 | 72 | 11 | miR-155, | miR-205, | miR-1224, | miR-379, | miR-4741, |
miR-762, | miR-4689, | miR-4484, | miR-3613, | miR-4739, | ||||
miR-20a | ||||||||
PI3K-Akt signaling pathway (hsa04151) | 2.74E-14 | 137 | 12 | miR-155, | miR-182, | let-7e, | miR-379, | miR-4459, |
miR-149, | miR-4668, | let-7f, | miR-199a, | miR-199b, | ||||
miR-3613, | miR-20a | |||||||
TGF-beta signaling pathway (hsa04350) | 5.88E-14 | 41 | 10 | miR-21, | miR-205, | let-7e, | miR-4668, | miR-451a, |
miR-4484, | let-7f, | miR-3613, | miR-20a, | miR-455 | ||||
ErB signaling pathway (hsa04012) | 1.17E-13 | 40 | 12 | miR-155, | miR-205, | miR-193a, | miR-200b, | miR-4530, |
miR-451a, | miR-4484, | miR-199a, | miR-199b, | miR-200c, | ||||
miR-3613, | miR-20a | |||||||
Transcriptional misregulation in cancer (hsa05202) | 1.23E-13 | 83 | 11 | miR-182, | miR-205, | miR-1224, | let-7e, | miR-1207, |
miR-149, | miR-4668, | let-7f, | miR-3613, | miR-20a, | ||||
miR-455 |